Felbor U, Benkwitz C, Klein M L, Greenberg J, Gregory C Y, Weber B H
Institute of Human Genetics, University Eye Hospital, University of Würzburg, Germany.
Arch Ophthalmol. 1997 Dec;115(12):1569-71. doi: 10.1001/archopht.1997.01100160739011.
Interfamilial phenotypic variations in Sorsby fundus dystrophy (SFD) have given rise to controversy as to whether SFD constitutes more than 1 nosologic entity. The recent identification of the tissue inhibitor of metalloproteinases-3 (TIMP3) as the gene causing SFD has made it possible to readdress the question of genetic and clinical heterogeneity. In this study, we have extended previous findings on a Ser181Cys founder mutation in SFD families from the British Isles and show that carriers of this mutation residing in Canada, the United States, and South Africa likewise are descendants of the British ancestor. In addition, we have reevaluated the question of variable SFD phenotypes by analyzing the available clinical data on carriers of the Ser181Cys mutation.
索斯比眼底营养不良(SFD)的家族间表型变异引发了关于SFD是否构成不止一种疾病实体的争议。最近鉴定出金属蛋白酶组织抑制剂-3(TIMP3)作为导致SFD的基因,使得重新探讨遗传和临床异质性问题成为可能。在本研究中,我们扩展了先前关于来自不列颠群岛的SFD家族中Ser181Cys奠基者突变的研究结果,并表明居住在加拿大、美国和南非的该突变携带者同样是英国祖先的后裔。此外,我们通过分析Ser181Cys突变携带者的现有临床数据,重新评估了SFD表型变异的问题。